APA
Cosman F., Crittenden D. B., Ferrari S., Khan A., Lane N. E., Lippuner K., Matsumoto T., Milmont C. E., Libanati C. & Grauer A. (20191024). FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab. : Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
Chicago
Cosman Felicia, Crittenden Daria B, Ferrari Serge, Khan Aliya, Lane Nancy E, Lippuner Kurt, Matsumoto Toshio, Milmont Cassandra E, Libanati Cesar and Grauer Andreas. 20191024. FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab. : Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
Harvard
Cosman F., Crittenden D. B., Ferrari S., Khan A., Lane N. E., Lippuner K., Matsumoto T., Milmont C. E., Libanati C. and Grauer A. (20191024). FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab. : Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
MLA
Cosman Felicia, Crittenden Daria B, Ferrari Serge, Khan Aliya, Lane Nancy E, Lippuner Kurt, Matsumoto Toshio, Milmont Cassandra E, Libanati Cesar and Grauer Andreas. FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab. : Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 20191024.